Tag: life sciences property
Breakthrough acquires life sciences development site in Philadelphia
Breakthrough Properties has acquired a site at 2300 Market in Philadelphia's Center City district to develop more than 200,000 square feet of best-in-class life science space. According to...
Oxford, Novaxia to invest €1bn in French life sciences development
Oxford Properties Group and French developer Novaxia have formed a strategic partnership to invest in life sciences development in France. Novaxia will act as development...
Life Science REIT acquires property in London’s Knowledge Quarter for £85m
Life Science REIT has acquired 7-11 Herbrand Street, an iconic Art Deco building close to University College Hospital and University College London in London's...
Trammell Crow to develop life science campus in Maryland
Global commercial real estate developer Trammell Crow Company (TCC) has unveiled plans to develop a life science campus, The Labs at Belward, in the...
Breakthrough makes second UK acquisition this year
Breakthrough Properties, a life science real estate investment firm, has expanded its European platform with the second acquisition in the UK this year. The company...
Breakthrough raises $3bn for life science real estate fund
Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, has raised $3 billion for its Breakthrough Life Science Property Fund. The $3 billion raised in fund...
BioMed Realty grows Seattle portfolio with South Lake Union acquisition
BioMed Realty has made its second investment in Seattle this quarter with the acquisition of 1101 Westlake, the 154,000-square-foot lab capable building located in...
Oxford, Reef to develop life sciences hub in central London
Guy’s & St Thomas’ Foundation has selected the partnership between Oxford Properties and Reef Estates Limited to develop Snowsfields Quarter, a life sciences hub...
Clarion Partners fund enters San Diego life sciences market
Clarion Partners Real Estate Income Fund (CPREIF) has entered the San Diego life sciences market with the acquisition of Fusion Life Science HQ, a 121,541...
BioMed Realty buys premier site in Seattle
BioMed Realty, a Blackstone portfolio company, has acquired Denny Park South site in Seattle, Washington. Denny Park South site represents more than 600,000 square-feet...